AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Tumor cells expressing membrane-bound TNF activate macrophages.

Vaccine Weekly

| September 17, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Tumor cells expressing membrane-bound tumor necrosis factor activate macrophages and have a compromised growth in immunosuppressed and immunodeficient mice.

According to recent research from Hungary, "Tumor necrosis factor (TNF)-alpha producing tumors as vaccines were demonstrated to induce a therapeutic anti-tumor immune response, but their clinical use is limited by the toxicity of soluble TNF. We investigated the growth characteristics and immunomodulatory properties of HeLa cells producing an uncleavable transmembrane form of TNF (preTNF)."

"The growth of the transformed tumors was compromised in both immunosuppressed and severe combined immunodeficient mice; no signs of TNF toxicity were detected," reported Tunde Nagy and colleagues at the Hungarian Academy of Sciences, University of Debrecen, and Szeged University. "Macrophages co-cultured with the transformed cells showed increased phagocytosis and cytokine production, indicating that activated macrophages may ...

Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results

Source: HighBeam Research, Tumor cells expressing membrane-bound TNF activate macrophages.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA